Gene · 9211
Papers3,019
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,019
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| When Encephalitis Burns Out, Are You Left With a Spark? | Epilepsy Curr | 2022 | 36426184 | PubTator, text mining | PubMed |
| Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis. | Data Brief | 2022 | 36426082 | PubTator, text mining | PubMed |
| Evaluation of CSF albumin quotient in neuronal surface antibody-associated autoimmune encephalitis. | Fluids Barriers CNS | 2022 | 36419157 | PubTator, text mining | PubMed |
| A Case of Anti-Leucine-Rich Glioma-Inactivated Protein 1 (Anti-LGI1) Encephalitis With an Unusual Frontomesial Motor Cortex T2 MRI Hyperintensity. | Cureus | 2022 | 36415395 | PubTator, text mining | PubMed |
| Prognostic significance and extra-hypothalamus dysfunction of hyponatremia in anti-leucine-rich glioma-inactivated protein 1 encephalitis. | J Neuroimmunol | 2022 | 36410057 | PubTator, text mining | PubMed |
| An MRI-based joint model of radiomics and spatial distribution differentiates autoimmune encephalitis from low-grade diffuse astrocytoma. | Front Neurol | 2022 | 36408523 | PubTator, text mining | PubMed |
| Role of responsive neurostimulation and immunotherapy in refractory epilepsy due to autoimmune encephalitis: A case report. | Front Neurol | 2022 | 36408512 | PubTator, text mining | PubMed |
| Seizure outcome-related factors in autoimmune encephalitis: A systematic review and meta-analysis. | Front Neurol | 2022 | 36408506 | PubTator, text mining | PubMed |
| Paraneoplastic neurological syndrome caused by cystitis glandularis: A case report and literature review. | World J Clin Cases | 2022 | 36405293 | PubTator, text mining | PubMed |
| MOG antibody associated disease (MOGAD) presenting with extensive brain stem encephalitis: A case report. | eNeurologicalSci | 2022 | 36388768 | PubTator, text mining | PubMed |
| Anti-glycine receptor antibody-positive progressive encephalomyelitis with rigidity and myoclonus initially presenting with one-sided stiff face: A case report. | Front Neurol | 2022 | 36388210 | PubTator, text mining | PubMed |
| Anti-NMDA receptor encephalitis and MOG-associated demyelination - a case report with long-term follow-up and a systematic review. | BMC Neurol | 2022 | 36384491 | PubTator, text mining | PubMed |
| Rituximab Was Effective in Relieving Symptoms of Isaacs Syndrome: A Case Report. | Cureus | 2022 | 36381695 | PubTator, text mining | PubMed |
| Autoimmune encephalitis after BBIBP-CorV (Sinopharm) COVID-19 vaccination: a case report. | BMC Neurol | 2022 | 36376863 | PubTator, text mining | PubMed |
| Seizures in adults with suspected central nervous system infection. | BMC Neurol | 2022 | 36376810 | PubTator, text mining | PubMed |
| Updates on the Diagnosis and Treatment of Peripheral Autonomic Neuropathies. | Curr Neurol Neurosci Rep | 2022 | 36376534 | PubTator, text mining | PubMed |
| Anti-NMDAR encephalitis with GFAPα IgG: a case report. | BMC Neurol | 2022 | 36371153 | PubTator, text mining | PubMed |
| AI-CoV Study: Autoimmune Encephalitis Associated With COVID-19 and Its Vaccines-A Systematic Review. | J Clin Neurol | 2022 | 36367067 | PubTator, text mining | PubMed |
| Molecular Docking and Molecular Dynamics Studies Reveal Secretory Proteins as Novel Targets of Temozolomide in Glioblastoma Multiforme. | Molecules | 2022 | 36364024 | PubTator, text mining | PubMed |
| Clinical Management of Pathogen-Negative Tuberculous Meningitis in Adults: A Series Case Study. | J Clin Med | 2022 | 36362480 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9211/papers?page=41